Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion type Assertion NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_head.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion description "[We also found that cell lines express on average 11 druggable mutations, including frequent mutations (>20%) in the receptor tyrosine kinases AXL and EPHA2, which have not been previously considered as potential targets for colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_provenance.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion evidence source_evidence_literature NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_provenance.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion SIO_000772 25193853 NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_provenance.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion wasDerivedFrom befree-2016 NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_provenance.
- NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_assertion wasGeneratedBy ECO_0000203 NP1217427.RAdSyK7vv3Cq89eAf2nSarJJga92VkGS6VmxeqBVccKXQ130_provenance.